top of page
  • Grace Century

Grace Century President Scott Wolf Appointed as an Advisor to Board of Provia Laboratories

Scott Wolf, President and Director of Research for United Arab Emirates-based private equity firm Grace Century, has been appointed to the Business Advisory Board of Provia Laboratories LLC. Provia's branded "Store-A-Tooth" is a revolutionary product which cryogenically stores dental stem cells for future use in personalized and regenerative medicine.


RAS AL KHAIMAH, United Arab Emirates (PRNewswire) APR 12, 2017

Wolf has been directly associated with Provia since early in its inception, acting as a significant early-stage investor for Provia and assisting the company with strategic advice, investor relations, new business development and the ongoing introduction of capital via the Grace Century Member's network. He was also instrumental in securing new geographical markets like the Commonwealth of Independent States (Russian Commonwealth) and other markets such as Kazakhstan. Most recently, Wolf played a major role in the engagement of US Capital Partners, Inc. a private investment bank who are partnering with Provia for a $2M capital raise. Howard Greenman, CEO of Provia, said, "Scott has been an incredible member of the Provia team over the last three years. He immersed his group in the project right from the very beginning and has been instrumental in the raising of almost $10 million in early stage funding from Grace Century's impressively strong international member network. Scott has been a clear and insightful source of advice and direction to Provia across many areas of our business, and now is the right time to formally add him to our Advisory Board as Provia engages on an international expansion plan." Provia's "Store-A-Tooth" product gives families the opportunity to store mesenchymal stem cells found in their children's baby teeth and wisdom teeth for their future stem cell therapy needs. These particular stem cells can be used in the future for the for repair and regeneration of multiple tissue types including bone, cartilage, heart muscle, nerves and tendons, which makes them of special interest and attention within the field of regenerative medicine. Speaking from Dubai, United Arab Emirates, Wolf commented, "Grace Century's strategy from its inception back in 2010 was to focus on a small number of truly "game-changing" projects which have the potential to disrupt the industries that they are targeting and revolutionize existing practices. We take great care in selecting our projects; however we saw great potential in Provia right from the early stages of our relationship with them, both in terms of their dedication to product research and entrepreneurial spirit evident in the entire team. Their team is the "best of the best" in marrying science to business, and giving families globally a future opportunity of a healthier and fuller life. I am very pleased to become a formal member of their Advisory Board, and look forward to continuing my relationship, as an active part of the successful future of Provia." About Grace Century Grace Century FZ LLC is an International research and private equity consultancy located in Ras Al Khaimah, (north of Dubai) in the United Arab Emirates (UAE). Grace Century specializes in "game-changing" life science and health related private equity projects. For portfolio or company information please email info(at) or call +971 (0)7 206 8851 Please direct all media enquiries to info(at) or call +971 (0)52 712 1777 Website – Facebook – LinkedIn – Twitter – Blog – About Provia Provia is a revenue-generating stem cell processing, manufacturing, and bio-storage company with a leading position in dental stem cell storage and related services. Provia's primary service, Store-A-Tooth™, provides private storage of stem cells from children's teeth for future use in the child's personalized regenerative medicine. Store-A-Tooth™ is a similar service to cord blood stem cell banks like ViaCord (purchased by PerkinElmer) and Cord Blood Registry (purchased by AMAG Pharma). Provia has a proprietary set of protocols for cell processing, expansion, validation, and cryopreservation. Provia's laboratory provides these services under FDA guidelines for current good manufacturing practice (cGMP) for human cell and tissue products. or Source:

35 views0 comments
bottom of page